Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer

Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer

US Patent 12103922 · Granted Oct 1, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
Taking preventative action in a secure HIPAA-compliant environment with integrat2025
System and method for automated processing of electronic records with machine le2025
18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
Trifunctional constructs with tunable pharmacokinetics useful in imaging and ant2025
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2025
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2025
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2025